Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Class action filed
Quarterly results
Credit agrmnt [a]
CC transcript
Appointed director
Symmetry Medical Inc. (SMA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/30/2014 8-K Quarterly results
Docs: "Third Quarter Highlights:"
08/04/2014 8-K Quarterly results
Docs: "Second Quarter Highlights:"
05/01/2014 8-K Quarterly results
Docs: "Reiterates 2014 Financial Guidance"
10/31/2013 8-K Form 8-K - Current report
08/01/2013 8-K Quarterly results
Docs: "Reiterates 2013 Financial Guidance"
05/02/2013 8-K Quarterly results
Docs: "Reiterates 2013 Financial Guidance"
11/05/2009 8-K Quarterly results
Docs: "Symmetry Medical Reports Third Quarter 2009 Financial Results"
05/07/2009 8-K Quarterly results
Docs: "Symmetry Medical Reports First Quarter 2009 Financial Results"
11/12/2008 8-K Quarterly results
Docs: "Symmetry Medical Reports Third Quarter 2008 Financial Results"
08/02/2007 8-K Quarterly results
Docs: "Symmetry Medical Reports Second Quarter 2007 Results"
05/08/2007 8-K Quarterly results
Docs: "Form of Restricted Stock Agreement",
"Symmetry Medical Reports First Quarter 2007 Results"
11/02/2006 8-K Quarterly results
Docs: "Symmetry Medical Reports Third Quarter 2006 Results"
08/03/2006 8-K Quarterly results
Docs: "Symmetry Medical Reports Second Quarter 2006 Results"
05/04/2006 8-K Quarterly results
Docs: "Symmetry Medical Acquires Riley Medical Broadens Product Offering in Cases and Strengthens Customer Base Warsaw, Indiana,",
"Symmetry Medical Reports First Quarter 2006 Results"
11/03/2005 8-K Quarterly results
Docs: "$ 15,475 $ 4,849"
08/04/2005 8-K Quarterly results
Docs: "Symmetry Medical Reports Record Second Quarter Results Financial Highlights: - Revenue increased to $70.2 million, up 32.2% over second quarter 2004 - Net income increased to $8.6 million, or $0.25 per diluted share after a charge of $0.02, primarily for unrealized foreign exchange and interest rate swap valuation losses - In July 2005, completed an equity offering of approximately 11.0 million secondary shares and 0.5 million primary shares at $22.25 per share, thereby doubling the float - Increased total year guidance to $0.91 to $0.94 per diluted share, after an estimated $0.02 charge for secondary offering expenses"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy